These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
404 related items for PubMed ID: 16519751
1. Prevalence, susceptibility profile and proteinase production of yeasts causing vulvovaginitis in Turkish women. Ozcan SK, Budak F, Yucesoy G, Susever S, Willke A. APMIS; 2006 Feb; 114(2):139-45. PubMed ID: 16519751 [Abstract] [Full Text] [Related]
2. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use]. Saporiti AM, Gómez D, Levalle S, Galeano M, Davel G, Vivot W, Rodero L. Rev Argent Microbiol; 2001 Feb; 33(4):217-22. PubMed ID: 11833253 [Abstract] [Full Text] [Related]
3. Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006. Fan SR, Liu XP, Li JW. J Obstet Gynaecol Res; 2008 Aug; 34(4):561-6. PubMed ID: 18937710 [Abstract] [Full Text] [Related]
4. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006. Yang YL, Wang AH, Wang CW, Cheng WT, Li SY, Lo HJ, TSARY Hospitals. Diagn Microbiol Infect Dis; 2008 Jun; 61(2):175-80. PubMed ID: 18304773 [Abstract] [Full Text] [Related]
5. Prevalence, species distribution and antifungal sensitivity of vaginal yeasts in infertile women. Verghese S, Padmaja P, Asha M, Elizabeth SJ, Anitha A, Kundavi KM, Jayanthi N, Varma T. Indian J Pathol Microbiol; 2001 Jul; 44(3):313-4. PubMed ID: 12024920 [Abstract] [Full Text] [Related]
6. [Biofilm production and antifungal susceptibility patterns of Candida species]. Yücesoy M, Karaman M. Mikrobiyol Bul; 2004 Jul; 38(1-2):91-8. PubMed ID: 15293907 [Abstract] [Full Text] [Related]
7. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy. Antoniadou A, Torres HA, Lewis RE, Thornby J, Bodey GP, Tarrand JP, Han XY, Rolston KV, Safdar A, Raad II, Kontoyiannis DP. Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780 [Abstract] [Full Text] [Related]
9. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002. Yang YL, Li SY, Cheng HH, Lo HJ, TSARY Hospitals. Diagn Microbiol Infect Dis; 2005 Mar; 51(3):179-83. PubMed ID: 15766603 [Abstract] [Full Text] [Related]
10. In vitro susceptibility of 115 isolates of Candida to amphotericin B, fluconazole and itraconazole. Mallié M, Bastide JM. Drugs Exp Clin Res; 1996 Mar; 22(6):301-7. PubMed ID: 9034756 [Abstract] [Full Text] [Related]
11. In vitro susceptibility of yeasts isolated from patients in intensive care units to fluconazole and amphotericin B during a 3-year period. Kucukates E, Erturan Z, Susever S, Yegenoglu Y. APMIS; 2005 Apr; 113(4):278-83. PubMed ID: 15865609 [Abstract] [Full Text] [Related]
13. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. Sobel JD, Ohmit SE, Schuman P, Klein RS, Mayer K, Duerr A, Vazquez JA, Rampalo A, HIV Epidemiology Research Study (HERS) Group. J Infect Dis; 2001 Jan 15; 183(2):286-93. PubMed ID: 11204125 [Abstract] [Full Text] [Related]